Delivery Order SPE2DB22D1106-SPE2DB25FFFH0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for CellCept 500 mg tablets (500-count packages) valued at $12,029.30 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026. CellCept (mycophenolate mofetil) is an...
- The Defense Logistics Agency awarded a delivery order valued at $31,318.38 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $27,938 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) on August 25, 2025, with completion targeted for August 26, 2025. This non-set-aside, competitively awarded delivery order reflects a firm fixed-price contract structure and will be performed at the vendor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) valued at $7,854.18. The award was made on May 6, 2025, with an ultimate completion date of May 7, 2025, under a firm fixed-price delivery order arrangement. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a $13,249.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count units). The contract was competitively awarded without set-aside designation and is set for completion by September 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for CellCept 500 mg tablets (100 count) valued at $1,283.84, with an award date of August 13, 2025, and ultimate completion by August 14, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through...
- The Defense Logistics Agency awarded a $6,014.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 mg CellCept tablets (500 count) on June 4, 2025, with completion expected by June 5, 2025. This non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly used in military and veteran healthcare systems for organ transplant recipients and certain...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of CellCept 500 mg tablets (100-count packages) under a firm fixed-price contract valued at $4,349.15. This is a non-set-aside competitive award with an ultimate completion date of August 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,577.14 to AmerisourceBergen Drug Corp for the supply of CellCept 250 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly...
- The Defense Logistics Agency awarded a $3,611.49 delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count) under a firm fixed-price contract. The award was issued on September 15, 2025, with an ultimate completion date of September 16, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFH0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $9,754.64. This firm fixed-price delivery order, issued on August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The award was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. CellCept (mycophenolate mofetil) is an immunosuppressive medication commonly used in military and veteran healthcare systems for transplant rejection prevention and autoimmune conditions. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, supporting the Defense Health Agency and broader military healthcare programs. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare operations globally, with the company demonstrating consistent capability to fulfill federal procurement requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 8/26/25 |